Cargando…

Magnetic resonance imaging radiomics signatures for predicting endocrine resistance in hormone receptor-positive non-metastatic breast cancer

BACKGROUND: One-third of patients with hormone receptor (HR)-positive breast cancers fail to respond to hormone therapy, and some patients even progress within two years of adjuvant endocrine therapy (ET) toward primary endocrine resistance. However, there is no effective way to predict endocrine re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yaping, Li, Junwei, Liu, Yajing, Zhong, Ying, Ren, Wei, Tan, Yujie, He, Zifan, Li, Chenchen, Ouyang, Jie, Hu, Qiugen, Yu, Yunfang, Yao, Herui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449264/ https://www.ncbi.nlm.nih.gov/pubmed/34536884 http://dx.doi.org/10.1016/j.breast.2021.09.005

Ejemplares similares

A Noninvasive Tool Based on Magnetic Resonance Imaging Radiomics for the Preoperative Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
por: Li, Chenchen, et al.
Publicado: (2022)

Machine learning radiomics of magnetic resonance imaging predicts recurrence-free survival after surgery and correlation of LncRNAs in patients with breast cancer: a multicenter cohort study
por: Yu, Yunfang, et al.
Publicado: (2023)

Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics–Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer
por: Yu, Yunfang, et al.
Publicado: (2020)

Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study
por: Yu, Yunfang, et al.
Publicado: (2021)

Identification of a tumor immune-inflammation signature predicting prognosis and immune status in breast cancer
por: Liu, Yajing, et al.
Publicado: (2023)

Clinical Evidence of Chemotherapy or Endocrine Therapy Maintenance in Patients with Metastatic Breast Cancer: Meta-Analysis of Randomized Clinical Trials and Propensity Score Matching of Multicenter Cohort Study
por: Ren, Wei, et al.
Publicado: (2022)

Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma
por: Jiang, Yupeng, et al.
Publicado: (2022)

Deep learning magnetic resonance imaging predicts platinum sensitivity in patients with epithelial ovarian cancer
por: Lei, Ruilin, et al.
Publicado: (2022)

A radiomic signature based on magnetic resonance imaging to determine adrenal Cushing’s syndrome
por: Piskin, Ferhat Can, et al.
Publicado: (2023)

Can radiomics be used to detect hypoxic–ischemic encephalopathy in neonates without magnetic resonance imaging abnormalities?
por: Zhuang, Xiamei, et al.
Publicado: (2023)

A Potential Prognostic Marker for Recognizing VEGF-Positive Hepatocellular Carcinoma Based on Magnetic Resonance Radiomics Signature
por: Fan, Tingting, et al.
Publicado: (2022)

Radiomics signature extracted from diffusion-weighted magnetic resonance imaging predicts outcomes in osteosarcoma
por: Zhao, Shuliang, et al.
Publicado: (2019)

Radiomic and clinical data integration using machine learning predict the efficacy of anti-PD-1 antibodies-based combinational treatment in advanced breast cancer: a multicentered study
por: Zhao, Jianli, et al.
Publicado: (2023)

Magnetic resonance radiomics signatures for predicting poorly differentiated hepatocellular carcinoma: A SQUIRE-compliant study
por: Yang, Xiaozhen, et al.
Publicado: (2021)

Magnetic resonance imaging-based radiomics signature for preoperative prediction of Ki67 expression in bladder cancer
por: Zheng, Zongtai, et al.
Publicado: (2021)

Immune gene patterns and characterization of the tumor immune microenvironment associated with cancer immunotherapy efficacy
por: Lin, Lili, et al.
Publicado: (2023)

Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation
por: He, Zifan, et al.
Publicado: (2020)

Using radiomics based on multicenter magnetic resonance images to predict isocitrate dehydrogenase mutation status of gliomas
por: Liu, Yan, et al.
Publicado: (2023)

Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
por: D’Souza, Anishka, et al.
Publicado: (2018)

Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
por: Bian, Li, et al.
Publicado: (2020)

Preoperative Magnetic Resonance Imaging Radiomics for Predicting Early Recurrence of Glioblastoma
por: Wang, Jing, et al.
Publicado: (2021)

Cardiac magnetic resonance radiomics: basic principles and clinical perspectives
por: Raisi-Estabragh, Zahra, et al.
Publicado: (2020)

Radiomics with 3-dimensional magnetic resonance fingerprinting: influence of dictionary design on repeatability and reproducibility of radiomic features
por: Fujita, Shohei, et al.
Publicado: (2022)

Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer
por: Yu, Yunfang, et al.
Publicado: (2020)

Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results
por: Leithner, Doris, et al.
Publicado: (2019)

Machine Learning: Applications and Advanced Progresses of Radiomics in Endocrine Neoplasms
por: Wang, Yong, et al.
Publicado: (2021)

Image quality and evaluation ability of magnetic resonance imaging techniques for thyroid-associated ophthalmopathy: Dixon fat-suppression technique vs. spectral attenuated inversion recovery
por: Huang, Kai, et al.
Publicado: (2023)

Functional posterior communicating artery of patients with posterior circulation ischemia using phase contrast magnetic resonance angiography
por: Zhou, Wei, et al.
Publicado: (2019)

Magnetic resonance radiomics features and prognosticators in different molecular subtypes of pediatric Medulloblastoma
por: Chang, Feng-Chi, et al.
Publicado: (2021)

Radiomics Based on Multiparametric Magnetic Resonance Imaging to Predict Extraprostatic Extension of Prostate Cancer
por: Xu, Lili, et al.
Publicado: (2020)

Magnetic resonance imaging (MRI)-based radiomics for prostate cancer radiotherapy
por: Yang, Fei, et al.
Publicado: (2018)

Estimation of biological heart age using cardiovascular magnetic resonance radiomics
por: Raisi-Estabragh, Zahra, et al.
Publicado: (2022)

Magnetic resonance-based radiomics nomogram for predicting microsatellite instability status in endometrial cancer
por: Lin, Zijing, et al.
Publicado: (2022)

Progress of magnetic resonance imaging radiomics in preoperative lymph node diagnosis of esophageal cancer
por: Xu, Yan-Han, et al.
Publicado: (2023)

Magnetic resonance imaging-derived radiomic signature predicts locoregional failure after organ preservation therapy in patients with hypopharyngeal squamous cell carcinoma
por: Hsu, Che-Yu, et al.
Publicado: (2020)

Robustness of radiomic features in magnetic resonance imaging: review and a phantom study
por: Cattell, Renee, et al.
Publicado: (2019)

Machine Learning-Based Analysis of Magnetic Resonance Radiomics for the Classification of Gliosarcoma and Glioblastoma
por: Qian, Zenghui, et al.
Publicado: (2021)

Radiomics and Magnetic Resonance Imaging of Rectal Cancer: From Engineering to Clinical Practice
por: Coppola, Francesca, et al.
Publicado: (2021)

Artificial intelligence and radiomics in magnetic resonance imaging of rectal cancer: a review
por: Di Costanzo, Giuseppe, et al.
Publicado: (2023)

Biparametric magnetic resonance imaging-based radiomics features for prediction of lymphovascular invasion in rectal cancer
por: Tong, Pengfei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hpbh8g3mpii14uroee0607378l